Introduction
Since antiquity, Coptidis Rhizoma (Coptis) has been administered as an ancient remedy. In Traditional Chinese Medicine (TCM), coptis is used to treat conditions associated with Qingre Zaoshi (clearing heat and removing dampness), Xiehuo Jiedu (purging fire to eliminate toxin) such as diarrhea, eye inflammation and women's abdomen ailments [1, 2] . Recent studies have disclosed its potential to combat cancer, inflammation, fibrosis, viral and bacterial infections, and oxidation [3] [4] [5] [6] [7] [8] [9] [10] . Coptis and its main ingredient, berberine, show significant effects on cancer with a multiple targets including mitochondrial [11] , NAG-1 [12, 13] , topoisomerases [14] , estrogen receptors [15] , p53 [16, 17] , NF-κB [18, 19] and ROS [20] . Our previous studies indicated that Coptis extracts activated miR-21 and miR-23a in human liver cancer [21] , we also found that Coptis and berberine initiated autophagy in liver cancer by activating Beclin-1 and blocking mTOR-signaling way by suppressing the activity of Akt and inducing p38 MAPK activation [22] .
According to China Pharmacopoeia (2010), three species could be the resources of Coptis, including Coptis chinensis Franch, Coptis deltoidea C.Y. Cheng et Hsiao and Coptis teeta Wall [23] , among which Coptis chinensis Franch (Huanglian in Chinese, HL) and Coptis teeta Wall (Yun Huanglian or Yunlian, YHL) are two main medical products from Sichuan Province and Yunnan Province, respectively. Chemical analysis have determine Berberine to be Huanglian's active components, and other trace alkaloids include palmatine, columbamine, jatrorhizine, epiberberine, copsitine, and an aporphinoid alkaloid-magnoflorine [24] . However, it shall be necessary to provide scientific evidence to show the bioequivalence of HL and YHL in certain pharmacoligcal aspects.
In this study, we compared the chemical compositions and tumor suppressive effects in vitro between Huanglian and Yunlian. High performance liquid chromatography (HPLC) and HPLC combined with mass spectrometry (LC-MS) were facilitated to determine berberine and other alkaloids and their ratio. As we previously found that berberine effectively inhibited cell migration and invasion at low doses by induction of Rho GTPases including RhoA, Cdc42 and Rac1 [25] . Inhibition of huanglian and yunlian on migration and invasion in human hepatocellular carcinoma cell line MHCC97L was investigated in this study as well.
Materials and Methods

Preparation of HL and YHL Aqueous Extracts
Dried HL and YHL herbs were collected from Sichuan and Yunnan Province of China respectively and authenticated under the guidance of Chinese Pharmacopoeia (2010). They were identified by School of Chinese medicine, the University of Hong Kong. 500 g of each was boiled in 10 times of distilled water (w/v) at 100°C for 1 hour and percolated through filter paper (Whatman, pleated filter grade 597 1/2, 4-7 μm) and then sterilized by filtration through a 0.2 μm pore filter (Minisart ® -plus, Sartorius). The filtrate was further concentrated and the dry extract powder was collected and stored at -20°C until used.
Cell line
Human hepatocellular carcinoma cell line MHCC97L was kindly gifted by Dr. Man Kwan, Department of Surgery, and The University of Hong Kong. Cells were cultured in DMEM medium (Invitrogen, USA), and incubated in a humidified atmosphere containing 5% CO 2 at 37°C.
Identification of chemical composition of HL and YHL extracts by LC-MS
LC-MS (Thermo Finnigan, USA) was used to identify the chemical composition of HL and YHL extracts. Both HL and YHL extract powders were dissolved in methanol and diluted to proper concentration. 10 μl of sample solution was injected to the LC-MS [26] [27] [28] .
Quantification of active components of HL and YHL extracts by HPLC
HPLC (Water 996 Photodiode Array Detector, Waters 717plus Autosampler, Water 600S Controller, Empower Pro Analysis system, USA) was introduced to analyze the active components in herb extracts as described previously [29] [30] [31] .
Cell viability assay
In vitro cytotoxicity of HL and YHL extracts on MHCC97L cells was observed using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay system. 1×10
4 cells with 100 μl of medium per well were seeded in 96-well plates, incubated, and treated with different concentrations of HL and YHL for 24, 48, and 72 hrs, respectively. At the end of each treatment, 10 μl of MTT (5 mg/mL) was added to the well and incubated for 4 hrs. The absorbance was read at 575 nm with Multiskan MS microplate reader (Labsystems, Finland).
Annexin v/PI staining
Cells were seeded in 35-mm petri-dish with 80% confluence and treated with different concentrations of HL and YHL for 24 hrs. After treatment, cells were collected using micro-scraper (Corning, USA) and then centrifuged. To detect apoptosis in MHCC97L cells, Annexin V/PI double staining kit (Sigma-aldrich, USA) was introduced to quantify cell amount in different stages of cell death. Briefly, cells were resuspended in 1 mL of binding buffer containing 100 mM HEPES/ NaOH, 1.4 M NaCl, 25 mM CaCl 2 , pH 7.5. Then 5 μl of FITC-conjugated Annexin V (50 μg/mL) and 10 μl of propidium iodide (100 μg/mL) were added to the cell suspension. Incubation of cells was performed in dark for exactly 10 minutes at room temperature and detected by flow cytometer (Epics XL, Beckman Coulter, USA).
Wound healing assay
MHCC97L cells were seeded in 6-well plates and waited for full confluence attained. To introduce uniform wound on the confluent monolayer cells, a gap was scraped by using a micro-pipette tip on each well. After wound introduction, culture medium was replaced with fresh medium containing different concentrations of HL and YH. To compare the speed of wound closure between berberine treated and untreated cells, photographs were taken under 100x magnifications using phase-contrast microscopy immediately after wound incision (0 h) and after 24 hrs.
Invasion chamber assay
The experiment was conducted under the manufacturer's instruction (QCMT 96-well cell invasion assay kit, Millipore, USA). Briefly, 100 μl of pre-warmed serum free media was placed into the invasion chamber and the plate was incubated for 1 hour at room temperature. After rehydration of chamber, media were removed and 150 μl serum free media in the presence of 10% fetal bovine serum were added to the feeder tray. 100 μl serum free media with 1×10 4 MHCC97L cells were then placed into invasion chamber. A series of concentrations of agents were added to cell suspension and incubated for 24 hours at 37°C, 5% CO 2 . Then media with cell suspension in each chamber were discarded and the chamber plate was plated onto a new feeder tray containing 150 μl PBS in each well and incubated for 1 minute at room temperature. After rinsing with PBS as described, PBS was removed and 150 μl of pre-warmed cell detachment solution were added to the feeder tray and the chamber plate was incubated for 30 minutes at 37°C. This step was followed by addition of 50 μl of lysis buffer/dye and 15 minutes incubation at room temperature. 150 μl of the mixture was transferred to a new 96-well black plate and read it using 480/520 nm filters set using a fluorescence plate reader.
Statistical analysis
Data was computed using student T-test and expressed as mean ± SD. Experiments were repeated three times. P<0.05 was considered significantly difference.
Results
Identification of chemical composition in HL and YHL extracts by LC-MS
7 peaks, magnoflorine, columbamine, jatrorhizine, epiberberine, copsitine, palmatine, and berberine were identified as major alkaloids in both HL and YHL extracts as reported previously [26, 27] . No significant difference of chemical composition between HL and YHL extracts was observed ( Table 1) .
Quantification of active components in HL and YHL extracts by HPLC
Area of 5 main peaks were determined and calculated as a percentage of total area. Data indicated there was no difference between the two herbal extracts (Figure 1 and Table 1 ). It was shown that berberine is the major active compound in both HL and YHL. The yields of berberine in HL and YHL were 32.14% and 30.96% respectively. 
Cytotoxicity effects of HL and YHL extracts on MHCC97L cells
MHCC97L cells treated with HL and YHL extracts for 24, 48 and 72 hrs were conducted and calculated. To better examine the bioequivalence between HL and YHL, the IC50 value of HL and YHL was determined and the data was presented by showing the yield of berberine contained by the extracts. IC50 value for HL was 340, 170 and 170 μM for 24, 48 and 72 hours, respectively, while for YHL was 380, 150 and 180 μM. Both of HL and YHL extracts exhibited potent cytotoxicity on MHCC97L with a dose-dependent manner in 48 hours (Figure 2 ).
HL-and YHL-induced apoptosis in MHCC97L Cells
The results showed that HL and YHL significantly induced early and median apoptosis in MHCC97L cells after 24 hours treatment. The induction of apoptosis by HL and YHL was slightly enhanced in line with increased doses. There was no large difference in potency between HL and YHL for inducing apoptosis in the MHCC97L cell line ( Figure  3 ).
HL and YHL inhibit metastasis of MHCC97L cells by wound healing assay
It was observed that MHCC97L cells at the opposite edges of the wounds rapidly migrated toward each other after 24 hrs of incubation. With increasing doses, the speed of wound healing slowed down, the gap remained open, and only minimal cell proliferation on the 2 edges of the wound was observed when cells were incubated with 200 μM of HL and YHL. Cell motility was remarkably inhibited with HL and YHL exposure. Photographs of cells with different treatment were taken and displayed in Figure 4 .
HL and YHL inhibit invasion of MHCC97L cells
The results of chamber assay combined with MTT assay showed promising inhibitory effects of HL and YHL on the invasion of MHCC97L cell line. The results also showed that HL and YHL suppressed the metastasis of MHCC97L at the doses far lower than their IC50 values. HL and YHL showed no difference in their capability to suppress cell invasion ( Figure 5 ).
Discussion
In Chinese Pharmacopoeia, HL and YHL belong to the same genus, Coptis, and both herbs could be administered in Traditional Chinese Medicine clinics, and are important components in Chinese medicine herbal formulae. There are indications that both herbs possess similar characteristics and functions in clinical use. However, there are no signs of prior research to provide any scientific observation on the pharmacological similarities of HL and YHL. In this study, we have been able to identify the active ingredients in HL and YHL by LC-MS. The HPLC-UV chromatograms of HL and YHL extracts showed that there was no significant difference in the chemical composition between the two extracts. The quantification of active components in HL and YHL was obtained by HPLC where there were no remarkable variation of the yields of major active alkaloids observed between HL and YHL, indicating that HL and YHL share great similarities in chemical composition.
To compare the bioactivity of HL and YHL, MTT Assay and flow cytometry were employed. As we previously found that coptis and berberine effectively inhibit cell metastasis and invasion at low doses by induction of Rho GTPases including RhoA, Cdc42 and Rac1 [25] . Wound healing and invasion chamber assay were conducted to compare the inhibition of metastasis and invasion between HL and YHL. Both of HL and YHL showed similar cytotoxicity in serial concentrations. We used Annexin V/PI double-staining to monitor apoptosis induced by HL and YHL. Both HL and YHL can significantly induce apoptosis in MHCC97L cells after 24 hours treatment. There was no large difference in potency between HL and YHL for inducing apoptosis in the MHCC97L cell line. Wound-healing assay was introduced to qualitatively determine the migration of MHCC97L cells with exposure to HL and YHL. Cell motility was remarkably inhibited under exposure with either HL or YHL. Moreover, the results of invasion chamber assay indicated HL and YHL showed no difference in their capability to suppress cell invasion.
In conclusion, HL and YHL share great similarities in both chemical composition and inhibitory effect on HCC growth and metastasis. In addition, we also found that other ingredients in HL and YHL presented a synergetic interaction with berberine which increased the late effects on cancer (data not shown). This sheds light on the application of HL and YHL as HCC therapeutic agents and deserves further studies.
